로딩 중…
지수 로딩 중…
BCWORLD PHARM. Co., Ltd.
200780· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩3,370-1.46%
2026-06-19
Price Chart
BCWORLD PHARM. Co., Ltd.-19.03%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 35.94B KRW |
| Revenue | 79.81B KRW |
| Net Income | -983.6M KRW |
| Total Assets | 173.26B KRW |
| Net Assets | 72.36B KRW |
| Employees | 281 |
| Value | |
| P/B | 0.50x |
| P/S | 0.45x |
| EV/EBITDA | 4943.52x |
| Profitability | |
| ROE | -1.36% |
| ROA | -0.57% |
| Op. Margin | 0.03% |
| Revenue Growth | 25.36% |
| Earnings Growth | -762.47% |
| Financial Health | |
| Debt Ratio | 239.44% |
| Total Debt | 87.53B KRW |
| Cash | 3.52B KRW |
| Current Ratio | 0.56x |
| Dividend | |
| Div. Yield | 2.67% |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | -19.03% |
| 1M Return | -17.20% |
| From 52W High | -44.11% |
| 1Y MDD | -42.59% |
| Trading | |
| Volume | 19,485 shares |
| Foreign Own. | 0.88% |
| Per Share | |
| EPS | -235 KRW |
| BPS | 6,914 KRW |
Company Info
BC World Pharm, established in 1980 and renamed in 2007, was certified as an innovative pharmaceutical company in 2012, a status it holds until 2024. The company specializes in pharmaceutical manufacturing and sales, leveraging EU GMP/cGMP-level facilities to expand its domestic and international Contract Manufacturing Organization (CMO)/Contract Development and Manufacturing Organization (CDMO) businesses and exports to advanced and emerging markets. As an R&D-focused pharmaceutical company with original Drug Delivery System (DDS) technology, it invests about 12% of its sales into R&D, growing into a global healthcare enterprise. BC World Pharm is headquartered in Gyeonggi-do, Yeoju-si.